reported to CDC during this period. The median patient age was 62.5 years (range = 2 months to 79 years). Travel history in the year preceding the positive culture was reported for 18 patients; 10 did not travel outside the United States, including five from a single cluster. Six patients were hospitalized outside the United States: three in India, and one each in the Philippines, Romania, and Spain.
The Minnesota Department of Health initiated surveillance for all CRE species in Hennepin and Ramsey counties in 2012 and expanded surveillance statewide on January 1, 2016. Isolates submitted to the MDH Public Health Laboratory are tested for carbapenemases. During January 1, 2014-September 30, 2017, 149 (12%) of 1,241 CRE submitted were carbapenemaseproducing; the percentage did not differ between isolates from the more common (Klebsiella spp., Enterobacter spp., and E. coli) and the less common genera. Among the 149 CP-CRE isolates, all were from unique patients, and 20 (13.4%) were from less common genera. The most common organism and mechanism combinations among the less common genera were IMP-producing Providencia rettgeri (seven; 35%) and KPCproducing Citrobacter freundii (six; 30%) (Table) .
Epidemiologic data were available for the 20 Minnesota patients with CP-CRE from the less common genera; no clusters were identified. The median patient age was 56.5 years (range = 14-75 years), and 15 (75%) patients were hospitalized at the time of culture collection. Two patients were hospitalized internationally (one each in Kenya and Kuwait) in the year before their positive culture.
Less common Enterobacteriaceae genera appear to be a small but potentially important subset of CP-CRE; however, estimates of the true proportion of CP-CRE from these less common genera are limited by the lack of systematic testing. Of note, many of the carbapenemases in the less common CRE genera were not KPC. These were frequently identified in patients who did not report travel outside the United States in the year preceding their positive culture, indicating domestic acquisition. Clinicians should be aware that CRE from the less common genera can harbor carbapenemases and consider requesting carbapenemase testing from state public health laboratories to guide infection control practices and prevent further spread of these resistance mechanisms. CRE surveillance that includes a broader range of Enterobacteriaceae genera is being piloted in 10 states and will be critical for better understanding the potential impact of these less common genera on the spread of carbapenemases.
